Combination effect of SAHA and paclitaxel on ovarian cancer cells

Copyright information:Taken from "Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients"BMC Cancer 2006;6():183-183.Published online 11 Jul 2006PMCID:PMC1539015. Four hours after treatment with SAHA, OVCAR-3 and SK-OV-3 cells were exposed to paclitaxel for further 72 hours. Cytotoxic effects were assessed by Alamar Blue assay. Cell viabilities are expressed as the ratio of absorbance of treated to untreated cells. Means ± SD of 3 independent experiments in quadruplicates are shown.